Proactive - Interviews for investors

Gold Hydrogen Ltd (ASX:GHY) managing director Neil McDonald sits down with Proactive’s Jonathan Jackson to discuss the progress of its exploration of natural hydrogen and helium at the Ramsay Project on the Yorke Peninsula of South Australia. This quarter, the company completed Stage 1 testing and started the next exploration phase. High concentrations of both gases were confirmed in the Ramsay 2 well, with hydrogen purity levels reaching up to 95.8% (air-corrected) at approximately 531 metres deep. Helium levels during initial testing reached 17.5%, with recent results indicating an increase to 20%-25%.

Stage 2 testing has begun, focusing on dewatering the well to enhance gas flow to the surface. GHY identified a 180-metre-thick helium pay zone in Stage 1, indicating significant potential for commercial extraction. A 2D seismic survey was also completed to guide future drilling targets and well designs.

GHY holds one granted petroleum exploration licence (PEL 687) and has seven additional applications, covering about 75,332 square kilometres. The company ended the quarter with A$15.6 million, supporting its exploration and development plans, including establishing a contingent estimated gas resource for Ramsay.

The project's 2U (best estimate) prospective hydrogen resources stand at 1.313 million tonnes with a 10% commercialisation probability (PC). The helium resource (2U prospective) is estimated at 41 billion cubic feet (bcf) with a 10% PC. These resources are conceptual targets requiring further exploration and evaluation.

#ProactiveInvestors #GoldHydrogen #ASX #RamsayProject, #YorkePeninsula, #NaturalHydrogen, #HeliumExploration, #HydrogenPurity, #HeliumPurity, #Stage2Testing, #2DSeismicSurvey, #PEL687, #ExplorationGoals, #GasResources, #CommercialExtraction, #HydrogenResources, #HeliumResources, #EnergyExploration, #NaturalGas, #ResourceEvaluation, #AustralianExploration, #GasFlow.

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Ananda Developments Plc finance director Jeremy Sturgess-Smith tells Proactive's Stephen Gunnion the company's graduation to the senior Apex segment of the Aquis Stock Exchange Growth Markets marks a significant milestone, reflecting its adherence to strict corporate governance rules and increased market confidence.

Sturgess-Smith highlighted the company's growth, meeting criteria such as a market cap of at least £10 million and having 25% of its stock in public hands. He emphasised the importance of having two independent Non-Executive Directors, John Treacy and Professor Clive Page, who bring valuable experience and credibility.

The graduation to Apex is expected to enhance visibility, liquidity, and investor confidence. Ananda is considering dual listing on other trading platforms, including the Frankfurt Stock Exchange, to tap into markets with strong medical cannabis industries, and the OTCQB in New York as a long-term strategy.

Sturgess-Smith also provided updates on Ananda's two phase 2 clinical trials and the MRX1 study using mice. The company is on track to begin dosing later this year, with ongoing discussions with MHRA and ethics submissions. He invited investors to join Anand's AGM on Friday August hosted through Investor Meet Company: https://www.investormeetcompany.com/ananda-developments-plc/register

For more insightful videos, visit Proactive's YouTube channel. Don't forget to give this video a like, subscribe to our channel, and enable notifications for future content.

#AnandaDevelopments #AquisApex #ClinicalTrials #MedicalCannabis #CorporateGovernance #InvestorUpdates #StockMarket #FinanceDirector #ProactiveInvestors #Phase2Trials #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Polarean Imaging PLC CEO Christopher von Jako takes Proactive's Stephen Gunnion through the company's recent advancements and future plans.

Von Jako shared insights on the oversubscribed financing closed in June, highlighting the support from strategic investors, including NUKEM Isotopes and Bracco. The funds are being allocated to expand the commercial sales team and promote the adoption of Polarean's pulmonary functional Xenon MRI technology.

He also discussed the recent upgrades at the University of Virginia Health Hospital and the University of Kansas Medical Center, moving from research to clinical-grade polarizers. This follows similar upgrades at Cincinnati Children's Hospital and the University of Alabama, Birmingham. These upgrades are expected to drive wider adoption of Polarean's technology.

Additionally, von Jako announced the submission of an NDA supplement to the FDA to lower the age for XENOVIEW administration to six years old. This milestone could significantly expand the US market, particularly in pediatric pulmonary care, as Polarean's technology avoids ionizing radiation.

Looking ahead, Polarean remains focused on executing its five-pillar strategy for 2024, with continued growth and expansion of the commercial team to meet set targets.

Visit Proactive's YouTube channel for more videos, and don't forget to like, subscribe, and enable notifications for future content.

#PolareanImaging #MedicalTechnology #XenonMRI #PediatricCare #FDAApproval #HealthcareInnovation #ChristopherVonJako #Investors #PulmonaryHealth #MedicalResearch #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Awale Resources Ltd (TSX-V:ARIC) CEO Andrew Chubb talked with Proactive about the latest assays from drilling at the Charger and BBM targets at the Odienné project in Côte d'Ivoire. The first five holes of a 21-hole program have returned positive results. Chubb highlighted that nine holes were drilled at Charger and 12 at BBM, with the program covering nearly 7,000 meters.

Key findings include a 1,500-gram meter intercept at the Charger target and a follow-up 580-gram meter intercept. These results help connect the breccia system in the subsurface, providing targets for deeper drilling and potential volume expansion.

Chubb confirmed that these assays support the continuity of the breccia geology. He mentioned that four more holes at Charger have been drilled and are awaiting reporting. At BBM, 12 holes tested down dip and along strike, with results expected throughout the summer.

Drilling has paused for the rainy season but is set to resume by late September. Awale Resources is also preparing geochemical programs for its 100%-owned permits, promising an exciting field season ahead. The current drilling program is fully funded by the joint venture with Newmont, and the company is well-financed for its upcoming exploration efforts.

Don't forget to like this video, subscribe to our channel, and enable notifications for future updates from Proactive.

#AwaleResources #MiningUpdates #DrillingResults #OdienneProject #CoteDIvoire #GoldExploration #JuniorMining #ProactiveInvestors #AndrewChubb #MineralExploration #InvestingInGold

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Light Science Technologies Holdings PLC (AIM:LST) CEO Simon Deacon takes Proactive's Stephen Gunnion through the company's strong half-year results. Deacon highlighted the company's robust performance across its three key divisions: controlled environment agriculture, contract electronics manufacturing, and passive fire protection.

Revenues surged by 19.3%, with committed group forward orders at £5.2 million. Gross profit rose significantly to 26.6% from 20.9%. Deacon noted, "Our quoted pipeline continues to grow, now at £51 million." The company's strategy includes expanding its global presence, with new distribution agreements in South Africa, Australia, the Middle East, and the Americas.

Cash availability increased to £1.5 million, supported by an enhanced debt facility of £850,000. Two new board members, Dr Graham Cooley and Richard Mills, have joined, bringing valuable market experience. The acquisition of Tomtech has bolstered revenue in the controlled environment agriculture sector.

The Passive Fire Protection (PFP) division is poised for growth, targeting a £50 billion market opportunity in the UK. The company's innovative solutions, such as the injector-clad product, offer significant cost savings and minimal disruption during installation.

Light Science Technologies is also making strides in sensor technology for agriculture, aiming to reduce fertiliser waste and greenhouse gas emissions.

The company's Contract Electronics Manufacturing (CEM) division continues to thrive, with notable growth in the sports entertainment sector.

Deacon emphasised, "We are a growing company, increasing profit margins year on year, and our focus is to become cash-generative by 2025."

Visit Proactive's YouTube channel for more videos, and don't forget to give this video a like, subscribe to the channel, and enable notifications for future content.

#LightScienceTechnologies #HalfYearResults #SimonDeacon #AgricultureTech #ElectronicsManufacturing #FireProtection #RevenueGrowth #Investing #ProactiveInterviews #InnovationInTech #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Pantheon International Plc partner and co-manager of PIP Charlotte Morris speaks with Proactive's Stephen Gunnion about the FTSE 150 investment trust's key achievements and strategic initiatives over the past year.

Morris highlighted the successful completion of approximately £197 million in share buybacks, resulting in a 4.7% uplift in NAV. She also detailed the capital allocation policy introduced on June 1st, which balances ongoing share buybacks with new investment opportunities.

Additionally, Morris discussed the refinancing of Pantheon's £500 million revolving credit facility and a private placement of $150 million in loan notes, enhancing the company's liquidity. The portfolio saw a 5% increase in NAV driven by strong fundamentals, with direct investments now comprising 54% of the portfolio. Despite a challenging environment, Pantheon achieved a 20% uplift at exit across more than 400 exits, with a robust multiple of 3.2 times cost.

Looking ahead, Morris is optimistic about improving investment conditions and emphasised the board's commitment to broadening the investor base through transparency and targeted marketing campaigns. "We truly believe that Pip offers an attractive, risk-adjusted return to investors," said Morris, citing a 13.5% CAGR in NAV over the past decade.

Visit Proactive's YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel, and enable notifications for future content.

#PantheonInternational #PrivateEquity #InvestmentStrategy #ShareBuybacks #CapitalAllocation #InvestmentOpportunities #FinancialPerformance #MarketOutlook #ProactiveInvestors #PrivateEquityInvestment#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Dr. Seth Lederman, CEO of Tonix Pharmaceuticals, recently joined Steve Darling from Proactive to discuss the implications of a groundbreaking report from the US National Academies of Sciences, Engineering, and Medicine on long Covid. The report defines long Covid as a chronic condition encompassing multiple diagnosable disorders, thus paving the way for better understanding and treatment approaches.

A particularly significant finding in the report is the acknowledgment that fibromyalgia can now be diagnosed in patients with long Covid, which eliminates previous diagnostic uncertainties. This development is especially beneficial for Tonix Pharmaceuticals, as the company is advancing TNX-102 SL, a drug designed to treat fibromyalgia.

Dr. Lederman pointed out that this new diagnostic clarity could substantially broaden the addressable market for TNX-102 SL, which already targets approximately 10 million American adults diagnosed with fibromyalgia. Tonix Pharmaceuticals is in the final stages of developing TNX-102 SL, having received FDA Fast Track designation in recognition of its significant potential. The company has completed two statistically significant studies and is preparing a new drug application for submission.

Dr. Lederman, who has nearly 30 years of experience researching fibromyalgia, emphasized the potential impact of this report on the estimated 14 million Americans suffering from long Covid. This new diagnostic criterion could enable these individuals to access effective treatments for fibromyalgia, representing a significant advancement in patient care.

#proactiveinvestors #tonixpharmaceuticalsholdingcorp #nasdaq #tnxp

#TonixPharmaceuticals, #SethLederman, #LongCovid, #Fibromyalgia, #NationalAcademies, #USScience, #TNX102SL, #DrugDevelopment, #FDA, #FastTrack, #Pharmaceuticals, #Health, #MedicalResearch, #Covid19, #ChronicIllness, #Medicine, #Healthcare, #ScientificResearch, #NewDrugApplication, #FibromyalgiaTreatment#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) head of ESG, Colleen Parkins, discusses the company's 2023 ESG report with Proactive's Stephen Gunnion..

Parkins shared significant improvements and achievements highlighted in the report, emphasising a data-driven approach aligned with the Global Reporting Initiative.

Key achievements include the commissioning of a solar plant that provided 20% of the Blanket mine's power, reducing diesel consumption by 62% and greenhouse gas emissions by 14%. The company was awarded the Responsible Resourcing Award for climate at the Mining Indaba for this initiative. Additionally, the first phase of a new tailings storage facility was commissioned, improving water recycling and aligning with global tailings management standards.

Community projects were another focus, with $1.5 million invested, including upgrades to a local high school and clinic. The clinic improvements aim to provide better healthcare access for women.

Parkins also highlighted the company’s increased focus on ESG since her appointment in 2022 and the implementation of an electronic safety, health, and environment management system.

Visit Proactive's YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel, and enable notifications for future content.

#CaledoniaMining #ESG #SustainableMining #SolarEnergy #CommunityProjects #GreenInitiatives #MiningIndaba #GlobalReportingInitiative #TailingsManagement #ProactiveInvestors

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Nostra Terra Oil and Gas Company PLC (AIM:NTOG, OTC:NTOGF) CEO Paul Welch takes Proactive's Stephen Gunnion through the company's recent developments and future plans.

Welch highlighted that Nostra Terra is an onshore US producer with primary assets in East Texas and legacy assets in South and West Texas. Since joining as CEO two months ago, Welch has overseen a significant restructuring, focusing on profitable assets and reducing general and administrative costs.

Welch discussed the company's recent fundraise of £450,000 aimed at returning idle wells to production, which is expected to significantly boost daily production and cash flow. He also emphasised the potential of the Pine Mills field, which is projected to increase production and generate substantial revenue through optimised drilling techniques and 3D seismic analysis.

Welch shared his excitement about the future, stating, "We think we have about 85 barrels a day that we can return to production, potentially doubling our current output." He also mentioned the company's focus on cost-effective operations, saying, "The more revenue we can generate, the more profitable the company becomes."

Stay tuned to Proactive's YouTube channel for more updates from Nostra Terra and other industry insights. Don't forget to like, subscribe, and enable notifications for future content.

#NostraTerra #OilAndGas #EnergySector #PaulWelch #ProductionExpansion #Investing #TexasOil #SeismicAnalysis #RevenueGrowth #Fundraise #ProactiveInvestors #EnergyNews

#ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Ondo InsurTech PLC (LSE:ONDO) CEO Craig Foster speaks to Proactive's Stephen Gunniuon about the company's strong full-year 2024 growth and future strategies.

Foster highlighted the key achievements in the year to 31 March, including revenue growth of 29% and recurring revenue up by 41%.

The leader in claims prevention technology for the home insurance industry announced that its LeakBot water damage prevention system is now deployed in 111,000 homes and is used by 18 insurers worldwide. Foster emphasised that Ondo met all targets and delivered growth in line with broker forecasts.

Foster said Ondo's solutions have already shown significant returns on investment and high customer satisfaction in the US.

He also discussed the company's strategy for 2025, which includes focusing on core markets in Scandinavia, the UK, and the US, and maintaining a consistent delivery model.

Don't miss more updates from Ondo InsurTech and other leading companies. Make sure to like this video, subscribe to our channel, and hit the notification bell for future content.

#OndoInsurTech #CraigFoster #InsuranceTechnology #LeakBot #HomeInsurance #RevenueGrowth #USExpansion #IoT #InvestorUpdate #ProactiveInvestors #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews